Shanghai Stock Exchange: Issued a public criticism notice to ST Hulawawa and relevant responsible persons.

The Shanghai Stock Exchange has issued a decision to criticize and notify Hainan Huludao Pharmaceutical Group Co., Ltd. and relevant responsible persons. The decision shows that Hainan Huludao Pharmaceutical Group Co., Ltd. has inaccuracies in the financial data disclosed in multiple periodic reports, involving a large amount of money and a high correction rate. Regarding responsible persons, the then Chairman and General Manager Liu Jingping, as the company's main person in charge and specific person in charge of daily operations, and the then CFO Yu Hui, as the specific person in charge of financial matters, did not fulfill their duties diligently, and are responsible for the company's violations. The Shanghai Stock Exchange has made the following disciplinary decision: to criticize and notify Hainan Huludao Pharmaceutical Group Co., Ltd., former Chairman and General Manager Liu Jingping, and former CFO Yu Hui.